5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Inhibition of multi-drug resistance (MDR) in NCI-AR xenografts by amplifying the necrosis cell death pathway
    Meeting Abstract

    Martin, D. S.; Alfieri, A. A.; Koutcher, J. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Thrombotic and hemorrhagic complications of prostate cancer: Challenges in diagnosis and treatment
    Meeting Abstract

    Kampel, L. J.
    Pathophysiology of Haemostasis and Thrombosis (2003)

    Fulltext@MSK | Save
  • Analysis of global gene expression patterns associated with interferon-alpha (IFN-alpha) resistance and response of renal cell carcinoma cells
    Meeting Abstract

    Banerjee, D.; Bourdon, V.; Chadalavada, R. S. V.; Houldsworth, J.; Motzer, R.; Chaganti, R. S. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Rapid MicroPET imaging of 17AAG induced HER2 protein downregulation using Ga-68-DOTA-F(ab ')(2) herceptin
    Meeting Abstract

    Smith-Jones, P. M.; Solit, D.; Afroze, F.; Akhurst, T.; Rosen, N.; Larson, S. M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Phase I trial of a recombinant soluble prostate-specific membrane antigen (rsPSMA) vaccine
    Meeting Abstract

    Slovin, S. F.; Gardner, J. P.; Morrissey, D. M.; Donovan, G. P.; Surowitz, K. G.; Olson, W. C.; Scher, H. I.; Israel, R. J.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras
    Meeting Abstract

    Sawai, A.; Basso, A. D.; Solit, D. B.; She, Q. B.; Grbovic, O.; Pratilas, C.; Chapman, P.; Moasser, M. M.; Rosen, N.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • The revised Memorial Anxiety Scale for Prostate Cancer (MAX-PC): Further validation of a scale to measure anxiety in men with prostate cancer
    Meeting Abstract

    Roth, A.; Rosenfeld, B.; Warshowsky, A.; O'Shea, N.; Reynolds, T.; Scher, H. I.; Breitbart, W.
    Psycho-Oncology (2003)

    Fulltext@MSK | Save
  • The long term follow up of bilateral sporadic renal tumors
    Meeting Abstract

    Patel, M. I.; Simmons, R.; Kattan, M. W.; Motzer, R.; Reuter, V.
    Annals of Surgical Oncology (2003)

    Fulltext@MSK | Save